🇮🇪Ireland
16°C Partly Cloudy · Dublin
Live Updates
--:--:-- IST
Writer Login
Latest
Clinical Trials in Turkey / NCT07381166
Recruiting Not applicable

The Effect of İnhaler Training and Reminders on Medication on Adherence in Elderly Individuals

NCT07381166 · tracked via the Priya Life Science Turkey tracker
Phase
Not applicable
Started
2026-01-21
Last updated
2026-03-09

Condition(s) studied

Elderly (People Aged 65 or More)

Investigational drug(s) / intervention(s)

Metered Dose Inhaler TrainingMetered Dose Inhaler Reminder CardMetered Dose Inhaler Application Video

Metered Dose Inhaler Training: It is known that incorrect inhaler use is more common, especially in elderly individuals, and that common errors in metered-dose inhaler use include poor hand-mouth coordination, inability to simultaneously spray and inhale, and failure to hold the breath during inhalation. This study evaluates metered-dose inhaler use only in elderly individuals. Furthermore, not only will the inhaler application steps be evaluated, but the experimental group will also receive education and reminder interventions.

Metered Dose Inhaler Reminder Card: This reminder card contains the inhaler administration steps included in the "Measured Dose Inhaler Medication Use Skill Chart". Participants in the experimental group will be able to access the medication administration steps on the reminder card before administering their inhaler medication. Participants will be asked in the final interview whether they used the reminder cards.

Metered Dose Inhaler Application Video: This video was prepared by the responsible researcher, taking into account the application steps included in the "Metered Dose Inhaler Medication Use Skill Chart". Participants in the experimental group will be able to access the application steps via the inhaler video before administering their inhaler medication.

Study summary

This study will evaluate the effect of metered-dose inhaler training and reminders on treatment adherence in elderly individuals.

Eligibility

Sex
ALL
Min age
65 Years
Max age
—
Healthy volunteers
No
Inclusion criteria for the study: * Age ≥ 65 years old * Having at least basic literacy, * Receiving metered-dose inhaler therapy for at least 6 months, * Being hospitalized in the pulmonary ward, * Presenting to the pulmonary function test unit, * Presenting to the pulmonary outpatient clinic, * Signing the informed consent form for participation in the study, * Having internet access and a mobile device with Android/iOS operating system, * Being able to use a telephone, * Having no communication barriers, * Being able to use the inhaler without needing assistance, * Making an error in at least one of the usage steps according to the MDI usage skills chart. Exclusion criteria for the study: * Age \<65 * Illiteracy * Receiving metered-dose inhaler therapy for \<6 months * Outpatient treatment * Being hospitalized in the intensive care unit * Being hospitalized in wards other than the pulmonary ward (such as surgery, physical therapy) * Visiting outpatient clinics other than the pulmonary clinic (such as surgery, physical therapy) * Not signing the informed consent form for participation in the study * Not having internet access and a mobile device with Android/iOS operating system * Not having telephone skills * Having communication barriers * Requiring assistance while using the inhaler * Not making any errors in the usage steps according to the MDI usage skills chart * Wanting to withdraw from the study/withdrawing from participation during the research process * Not completing the questionnaire

Primary outcome measure(s)

Trial sites (1)

FacilityCityRegionStatus
Department of Nursing, Faculty of Health Sciences, Canakkale Onsekiz Mart University Çanakkale Turkey (Türkiye) Recruiting

More Çanakkale Onsekiz Mart University trials in Turkey

Other trials for the same condition

Official registry record

This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.

View NCT07381166 on ClinicalTrials.gov ↗ ← All trials in Turkey